ATE118503T1 - 6-0-methylerythromycin-a-oximderivate. - Google Patents

6-0-methylerythromycin-a-oximderivate.

Info

Publication number
ATE118503T1
ATE118503T1 AT90310923T AT90310923T ATE118503T1 AT E118503 T1 ATE118503 T1 AT E118503T1 AT 90310923 T AT90310923 T AT 90310923T AT 90310923 T AT90310923 T AT 90310923T AT E118503 T1 ATE118503 T1 AT E118503T1
Authority
AT
Austria
Prior art keywords
group
substituted
benzyl
groups
phenyl
Prior art date
Application number
AT90310923T
Other languages
English (en)
Inventor
Yoko Misawa
Toshifumi Asaka
Masato Kashimura
Shigeo Morimoto
Yoshiaki Watanabe
Katsuo Hatayama
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE118503T1 publication Critical patent/ATE118503T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT90310923T 1989-10-07 1990-10-04 6-0-methylerythromycin-a-oximderivate. ATE118503T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26279789 1989-10-07

Publications (1)

Publication Number Publication Date
ATE118503T1 true ATE118503T1 (de) 1995-03-15

Family

ID=17380743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90310923T ATE118503T1 (de) 1989-10-07 1990-10-04 6-0-methylerythromycin-a-oximderivate.

Country Status (10)

Country Link
US (1) US5302705A (de)
EP (1) EP0422843B1 (de)
JP (1) JPH03204893A (de)
KR (1) KR910007953A (de)
AT (1) ATE118503T1 (de)
CA (1) CA2027074A1 (de)
DE (1) DE69016912T2 (de)
DK (1) DK0422843T3 (de)
ES (1) ES2071036T3 (de)
TW (1) TW199098B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260938B1 (de) 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin-A-Derivate und Verfahren zu ihrer Herstellung
AU3192695A (en) * 1994-08-12 1996-03-07 Taisho Pharmaceutical Co., Ltd. Interleukin-5 production inhibitor
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
ATE275151T1 (de) * 1998-03-03 2004-09-15 Pfizer Prod Inc 3,6-ketal-makrolidantibiotika
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
CA2411293A1 (en) 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
AR023264A1 (es) * 1999-04-08 2002-09-04 Hokuriku Pharmaceutical Derivados de eritromicina
KR100428703B1 (ko) * 2000-02-02 2004-04-30 한국과학기술연구원 헬리코박터 파이로리의 성장 억제 효과를 지닌 신규 마크로라이드 화합물
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
DK109886A (da) * 1985-03-12 1986-09-13 Beecham Group Plc Erythromycinderivater
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
EP0260938B1 (de) * 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin-A-Derivate und Verfahren zu ihrer Herstellung
AU1204288A (en) * 1987-02-24 1988-08-25 Beecham Group Plc Erythromycins

Also Published As

Publication number Publication date
ES2071036T3 (es) 1995-06-16
DK0422843T3 (da) 1995-04-03
US5302705A (en) 1994-04-12
TW199098B (de) 1993-02-01
EP0422843A3 (en) 1991-09-18
KR910007953A (ko) 1991-05-30
DE69016912T2 (de) 1995-07-06
JPH03204893A (ja) 1991-09-06
DE69016912D1 (de) 1995-03-23
CA2027074A1 (en) 1991-04-08
EP0422843B1 (de) 1995-02-15
EP0422843A2 (de) 1991-04-17

Similar Documents

Publication Publication Date Title
BR9703447A (pt) Novos compostos 3-(piperid-4-il)-1,2-benzisoxazol e 3-(piperazin-4-il) 1,2-benzisoxazol processos para a preparação dos mesmos e composições farmacêuticas contendo os mesmo
DK0418175T3 (da) Isoxazoler som herbicider
DE69016912D1 (de) 6-0-Methylerythromycin-A-Oximderivate.
DK1105393T3 (da) Bicykliske piperidin- og piperazinforbindelser med 5-HT6-receptoraffinitet
FI923264A0 (fi) Nya herbicider.
DE3888756D1 (de) Carbamoylpyrrolidonderivate, ihre Verwendung und Herstellung.
NO904300D0 (no) Kinolinderivater samt fremstilling og anvendelse derav.
ATE74608T1 (de) Chinolincarbonsaeure-derivate.
ATE107632T1 (de) Pyrimidinyl herbizides mittel.
DK0404359T3 (da) Dibenzothiazepin-derivater, der er nyttige som antispasmodiske midler
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
DE3581029D1 (de) Substituierte carbodiimide.
SE9001269L (sv) 2-substituerade n,n'-ditrimetoxbensoylpiperaziner, en framstaellningsmetod foer dessa samt terapeutiska kompositioner som innehaaller dem
ATE191458T1 (de) Benzol-derivate
ATE226572T1 (de) Kondensierte indan-derivate und ihre salze
DK0435235T3 (da) Nye isoquinolinderivater og salte deraf
FI956016A0 (fi) 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina
ATE5724T1 (de) Guanidinverbindungen, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
TH18321A (th) สารออกฤทธิ์ต้านตัวรับแทคิไคนินชนิดนอนเพปไทด์
TH27618B (th) สารประกอบเพนทะไซคลิค
TH8571A (th) สารฆ่าอาร์โธรพอดชนิดซับสทิทิวเทดเซมิคาร์มาโซน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee